Title : Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.

Pub. Date : 2013 Mar

PMID : 23340716






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib is a proteasome inhibitor and a drug used for molecular-targeted therapy (targets NF-kappaB). Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
2 We demonstrate that bortezomib inhibits NF-kappaB activity and cell proliferation. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
3 The combined treatment with bortezomib and radiation (RT) suppressed NF-kappaB activity and cell growth in vitro and in vivo compared with RT treatment alone. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
4 To investigate the mechanisms by which bortezomib suppresses tumor growth, the expression of signaling molecules downstream of NF-kappaB were examined by ELISA. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
5 A novel molecular targeting therapy including bortezomib may be effective in the treatment of oral cancer by suppressing NF-kappaB activity. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens